CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing the therapeutic potential of peptides by combining them with dendrimers. It aims to improve drug delivery and efficacy for specific biomedical targets through innovative synthetic strategies.
Peptides have emerged as a therapeutically important class of drugs and offer the advantage of great specificity, potency and low toxicity.
Short circulation half-life, poor proteolytic stability and bioavailability have however prevented them from becoming a mainstream source of drug candidates.
Dendrimers are versatile, derivatizable, well-defined branched synthetic macromolecules with promising properties for a variety of applications in technology and medicine.
Combining therapeutic peptides…
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
